MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis

    F. Gövert, J. Becktepe, B. Balint, J. Varley, S. Irani, M. Titulaer, J. de Vries, B. Joubert, J. Honnorat, H. Ariño Rodríguez, J. Dalmau, G. Deuschl, F. Leypoldt (Kiel, Germany)

    Objective: The aim of this study was (1) to investigate the prevalence of movement disorders in a large cohort of patients with encephalitis with LGI1…
  • 2019 International Congress

    Association of genetic polymophisms with pharmacokinetics of levodopa in South indian PD patients

    R. Borgohain, T. Sd, T. Syed, V. Kutala, R. Kandadai, S. Meka, S. Tandra (Hyderabad, India)

    Objective: To evaluate the role of COMT gene variations on the pharmacokinetics (PK) of L-dopa in PD patients. Background: Genetic variations in enzymes (MAO-B, COMT),…
  • 2019 International Congress

    Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite

    F. Naz, R. X, YHS. Siddique (Aligarh, India)

    Objective: To evaluate the behavioural changes in transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by different doses of Ropinirole alginate nanocomposite (RANC).…
  • 2019 International Congress

    Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

    D. Desai, S. Singh, S. Desai (Anand, India)

    Objective: To assess the prevalence of Axis-1 DSM-4 [The Diagnostic and Statistical Manual of Mental disorders] psychiatric disorders in patients with Parkinson’s disease [PD], atypical…
  • 2019 International Congress

    Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates

    M. Sommerauer, C. Schedlich-Teufer, P. Reker, E. Kalbe, J. Kessler, M. Barbe (Köln, Germany)

    Objective: To assess clusters of neuropsychiatric symptoms in Parkinson’s disease and their relation to motor symptoms and demographic markers in a large PD cohort. Background:…
  • 2019 International Congress

    Management of Patients with Functional Movement Disorders: A Transcultural Perspective

    C. Maurer, D. Anderson, A. Asadi-Pooya, J. Baizabal, M. Damianova, C. Ganos, R. Kanaan, M. Tijssen, J. Kwasa, I. Moreno, S. Pandey, JE. Park, D. Saylor, M. Stamelou, C. Stephen, T. Teodoro, M. Tinazzi, K. Lafaver (Stony Brook, NY, USA)

    Objective: To compare the clinical management, available resources and barriers to care for patients with functional movement disorders (FMD) across 15 countries around the globe.…
  • 2019 International Congress

    Evaluating IL6 and mitochondrial DNA levels as a potential biomarker in carriers of Parkin and PINK1 mutations

    M. Borsche, I. König, S. Delcambre, S. Petrucci, A. Balck, T. Gasser, N. Brüggemann, S. Pereira, K. Badanjak, K. Brockmann, E M. Valente, R. Youle, A. Grünewald, C. Klein (Lübeck, Germany)

    Objective: To discriminate affected PARK-Parkin and PARK-PINK1 mutation carriers from idiopathic Parkinson’s disease (PD) patients and healthy controls using serum IL-6 and mtDNA levels. Background:…
  • 2019 International Congress

    Spastic Paraplegia Type 64: a Case Series

    KCD. Donis, LAP. Paskulin, RBT. Tenório, JWR. Rocha, TOS. Silva, JMS. Saute (Porto Alegre, Brazil)

    Objective: to present four cases (two families) with a likely diagnosis of spastic paraplegia type 64 (SPG 64), broadening this disease phenotype. Background: SPG64 is…
  • 2019 International Congress

    The PLA2G6 Gene Mutation Causes Parkinson’s Disease: A Case Report

    L. Kou, T. Wang, L. Liu, GX. Zhang (Wuhan, China)

    Objective: To investigate the clinical features of Parkinson's disease caused by PLA2G6 gene mutation. Background: Early-onset Parkinsonism is a group of syndromes characterized by Parkinson's disease…
  • 2019 International Congress

    Prevalence of Fabry disease among patients with Parkinson’s disease

    A. Mosejova, S. Oppermann, V. Han, P. Dosekova, J. Cobejova, M. Cobej, P. Levicka, S. Liesenerova, T. Lorincova, M. Ostrozovicova, D. Sendekova, V. Sukovska, Z. Gdovinova, P. Bauer, M. Skorvanek (Kosice, Slovakia)

    Objective: To determine the prevalence of Fabry disease (FD) among patients with Parkinson’s disease (PD). Background: Increased prevalence of PD disease has been previously reported…
  • « Previous Page
  • 1
  • …
  • 123
  • 124
  • 125
  • 126
  • 127
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley